---
title: "Endocrinology"
order: 2
category: "Internal Medicine"
---

# Endocrinology

## Overview

Endocrinology is the medical specialty focused on the diagnosis and treatment of disorders affecting the endocrine system, which consists of hormone-producing glands that regulate metabolism, growth, reproduction, mood, and homeostasis. Endocrine disorders are among the most common chronic diseases, with diabetes mellitus affecting over 500 million people worldwide.

### Scope of Endocrinology
- **Diabetes mellitus**: Type 1, type 2, gestational diabetes, metabolic syndrome
- **Thyroid disorders**: Hypothyroidism, hyperthyroidism, thyroid nodules, thyroid cancer
- **Adrenal disorders**: Cushing's syndrome, Addison's disease, pheochromocytoma, hyperaldosteronism
- **Pituitary disorders**: Acromegaly, prolactinomas, hypopituitarism, diabetes insipidus
- **Reproductive endocrinology**: PCOS, hypogonadism, menopause
- **Bone and mineral metabolism**: Osteoporosis, hyperparathyroidism, vitamin D deficiency
- **Obesity and metabolic disorders**: Weight management, lipid disorders, metabolic syndrome

### Epidemiology
- Diabetes mellitus: 537 million adults worldwide (IDF 2021)
- Thyroid disorders: 5-10% of adults have hypothyroidism
- Metabolic syndrome: 20-25% of adults in developed countries
- Osteoporosis: 200 million women worldwide
- PCOS: 5-10% of women of reproductive age

### The Endocrine System

**Major endocrine glands**:
- **Hypothalamus**: Master regulator, produces releasing/inhibiting hormones
- **Pituitary gland**: "Master gland" (anterior and posterior lobes)
- **Thyroid gland**: Metabolism regulation (T3, T4, calcitonin)
- **Parathyroid glands**: Calcium homeostasis (PTH)
- **Adrenal glands**: Cortex (cortisol, aldosterone, androgens), medulla (catecholamines)
- **Pancreas**: Glucose regulation (insulin, glucagon)
- **Gonads**: Sex hormones (estrogen, progesterone, testosterone)
- **Pineal gland**: Melatonin production

## Hormonal Regulation Principles

### Feedback Mechanisms

**Negative feedback**:
- Most common regulatory mechanism
- Hormone inhibits its own secretion
- Example: Thyroid axis (T3/T4 suppress TSH)
- Maintains homeostasis

**Positive feedback**:
- Less common, amplifies response
- Example: LH surge triggering ovulation
- Self-limiting once endpoint reached

**Hypothalamic-pituitary axes**:
- HPT axis: TRH → TSH → T3/T4
- HPA axis: CRH → ACTH → cortisol
- HPG axis: GnRH → LH/FSH → sex steroids

### Hormone Transport and Action

**Hormone types**:
- **Peptide/protein hormones**: Insulin, growth hormone, TSH (water-soluble, cell surface receptors)
- **Steroid hormones**: Cortisol, aldosterone, sex hormones (lipid-soluble, intracellular receptors)
- **Amino acid derivatives**: Thyroid hormones, catecholamines

**Binding proteins**:
- Increase hormone half-life
- Provide reservoir for free hormone
- Examples: SHBG, CBG, TBG
- Free hormone is biologically active

## Diagnostic Approaches in Endocrinology

### Clinical Assessment

**History**:
- Weight changes (gain or loss)
- Energy level and fatigue
- Temperature intolerance (heat or cold)
- Changes in skin, hair, nails
- Menstrual irregularities
- Polyuria, polydipsia, polyphagia
- Sexual dysfunction
- Growth and developmental concerns
- Family history of endocrine disorders

**Physical examination**:
- Vital signs: Blood pressure, heart rate, temperature
- Body habitus: Distribution of fat, muscle wasting
- Skin: Hyperpigmentation, striae, acanthosis nigricans, vitiligo
- Thyroid: Palpation for size, nodules, tenderness
- Visual fields: Bitemporal hemianopsia (pituitary tumor)
- Hirsutism or virilization
- Goiter or thyromegaly

### Laboratory Testing

**Hormone measurements**:
- Basal levels: TSH, free T4, cortisol, testosterone
- Dynamic testing: Stimulation and suppression tests
- 24-hour urine collections: Free cortisol, metanephrines
- Timing considerations: Cortisol (morning), prolactin (fasting)

**Common dynamic tests**:
- **ACTH stimulation test**: Adrenal insufficiency
- **Dexamethasone suppression test**: Cushing's syndrome
- **Oral glucose tolerance test**: Diabetes, acromegaly
- **Water deprivation test**: Diabetes insipidus
- **Thyroid uptake scan**: Hyperthyroidism etiology

### Imaging

**Thyroid imaging**:
- Ultrasound: First-line for nodule evaluation
- Radioiodine uptake and scan: Hyperthyroidism etiology
- FNA biopsy: Nodules >1 cm or suspicious features

**Pituitary imaging**:
- MRI with gadolinium: Gold standard for pituitary tumors
- Visual field testing: Assess optic chiasm compression

**Adrenal imaging**:
- CT or MRI: Adrenal masses
- Adrenal vein sampling: Lateralization in hyperaldosteronism
- MIBG scan: Pheochromocytoma/paraganglioma

**Bone density**:
- DEXA scan: Osteoporosis screening and monitoring
- T-score and Z-score interpretation

## Common Endocrine Disorders

### Diabetes Mellitus
- Type 1 diabetes: Autoimmune beta cell destruction
- Type 2 diabetes: Insulin resistance and relative deficiency
- Gestational diabetes: Glucose intolerance during pregnancy
- Diabetic ketoacidosis: Acute complication of type 1 DM
- Hyperosmolar hyperglycemic state: Acute complication of type 2 DM
- Chronic complications: Retinopathy, nephropathy, neuropathy, cardiovascular disease

### Thyroid Disorders
- Hypothyroidism: Primary (thyroid) vs. secondary (pituitary)
- Hyperthyroidism: Graves' disease, toxic adenoma, thyroiditis
- Thyroid nodules: Evaluation and management
- Thyroid cancer: Papillary, follicular, medullary, anaplastic

### Adrenal Disorders
- Cushing's syndrome: Excess cortisol
- Addison's disease: Primary adrenal insufficiency
- Pheochromocytoma: Catecholamine-producing tumor
- Primary hyperaldosteronism: Excess aldosterone

### Pituitary Disorders
- Acromegaly: Growth hormone excess
- Prolactinoma: Prolactin-secreting adenoma
- Hypopituitarism: Deficiency of pituitary hormones
- Diabetes insipidus: ADH deficiency or resistance

### Reproductive Endocrinology
- Polycystic ovary syndrome (PCOS)
- Hypogonadism (male and female)
- Hyperprolactinemia
- Infertility

### Bone and Mineral Disorders
- Osteoporosis: Decreased bone density
- Primary hyperparathyroidism: Excess PTH
- Hypoparathyroidism: PTH deficiency
- Vitamin D deficiency and insufficiency

## Endocrine Pharmacology

### Diabetes Medications

**Insulin**:
- Rapid-acting: Lispro, aspart, glulisine
- Short-acting: Regular insulin
- Intermediate-acting: NPH
- Long-acting: Glargine, detemir, degludec

**Oral hypoglycemics**:
- Metformin: First-line for type 2 DM
- Sulfonylureas: Glipizide, glyburide (insulin secretagogues)
- DPP-4 inhibitors: Sitagliptin, linagliptin
- GLP-1 agonists: Liraglutide, semaglutide (injectable)
- SGLT2 inhibitors: Empagliflozin, dapagliflozin
- Thiazolidinediones: Pioglitazone

### Thyroid Medications

**Hypothyroidism**:
- Levothyroxine (T4): Standard treatment
- Liothyronine (T3): Rarely used
- Combination therapy: Controversial

**Hyperthyroidism**:
- Methimazole: First-line antithyroid drug
- Propylthiouracil: Pregnancy, thyroid storm
- Beta-blockers: Symptom control
- Radioactive iodine: Definitive treatment
- Surgery: Thyroidectomy

### Osteoporosis Medications

**Antiresorptive agents**:
- Bisphosphonates: Alendronate, risedronate, zoledronic acid
- Denosumab: RANKL inhibitor
- Selective estrogen receptor modulators: Raloxifene

**Anabolic agents**:
- Teriparatide: PTH analog
- Abaloparatide: PTH-related peptide analog
- Romosozumab: Sclerostin inhibitor

### Reproductive Hormones

**Contraceptives**:
- Combined oral contraceptives (estrogen + progestin)
- Progestin-only pills
- Long-acting reversible contraceptives (IUDs, implants)

**Hormone replacement therapy**:
- Estrogen therapy (with or without progestin)
- Testosterone replacement (gels, injections, patches)

## Metabolic Syndrome

### Diagnostic Criteria (NCEP ATP III)

**At least 3 of the following**:
- Waist circumference: >40 inches (men), >35 inches (women)
- Triglycerides: ≥150 mg/dL
- HDL cholesterol: <40 mg/dL (men), <50 mg/dL (women)
- Blood pressure: ≥130/85 mmHg
- Fasting glucose: ≥100 mg/dL

### Management

**Lifestyle interventions**:
- Weight loss: 5-10% body weight reduction
- Physical activity: 150 minutes/week moderate intensity
- Dietary modifications: Mediterranean diet, DASH diet
- Smoking cessation

**Pharmacologic therapy**:
- Metformin: Consider for prediabetes
- Statins: Dyslipidemia management
- Antihypertensives: Target BP <130/80 mmHg
- Consider GLP-1 agonists or SGLT2 inhibitors for weight loss

## Endocrine Emergencies

### Diabetic Ketoacidosis (DKA)
- Hyperglycemia, ketosis, metabolic acidosis
- Treatment: IV fluids, insulin, electrolyte replacement
- Monitor for complications: Cerebral edema, hypokalemia

### Hyperosmolar Hyperglycemic State (HHS)
- Severe hyperglycemia without ketosis
- Profound dehydration and hyperosmolality
- Treatment: Aggressive IV hydration, insulin

### Thyroid Storm
- Life-threatening thyrotoxicosis
- Treatment: PTU or methimazole, beta-blockers, steroids, iodine

### Myxedema Coma
- Severe hypothyroidism with altered mental status
- Treatment: IV levothyroxine, steroids, supportive care

### Adrenal Crisis
- Acute adrenal insufficiency
- Treatment: IV hydrocortisone, fluid resuscitation, treat precipitant

### Hypercalcemic Crisis
- Severe hypercalcemia (>14 mg/dL) with symptoms
- Treatment: IV fluids, calcitonin, bisphosphonates

## Key Points

- Endocrine disorders affect multiple organ systems and require comprehensive evaluation including hormone testing and dynamic studies
- Diabetes mellitus is the most common endocrine disorder, requiring individualized treatment based on type and patient factors
- Thyroid disease is highly prevalent; TSH is the best screening test for thyroid dysfunction
- Recognition and treatment of endocrine emergencies (DKA, thyroid storm, adrenal crisis) is critical for preventing mortality
- Many endocrine disorders require lifelong hormone replacement therapy and regular monitoring
- Metabolic syndrome represents a cluster of risk factors that significantly increase cardiovascular disease risk

## References

1. Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2019.

2. Gardner DG, Shoback D. Greenspan's Basic & Clinical Endocrinology. 10th ed. McGraw-Hill Education; 2017.

3. Jameson JL, De Groot LJ. Endocrinology: Adult and Pediatric. 7th ed. Elsevier; 2015.

4. American Diabetes Association. Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S1-S291.

5. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.

6. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.

7. Nieman LK, Biller BM, Findling JW, et al. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540.

8. Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(11):3888-3921.

9. Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951.

10. Camaschella C. Iron-Deficiency Anemia. N Engl J Med. 2015;372(19):1832-1843.
